The global contrast media injectors market is expected to reach USD 1.4 billion by 2025,
growing at a CAGR of 5.8%, according to a new report by Grand View Research,
Inc. Rising demand for minimally invasive surgical procedures is a major factor
expected to boost the market during the forecast period. These devices assist
surgeons in accurate insertion of contrast agents with reduced human errors,
thus increasing the accuracy and efficiency of surgical procedures. They play a
crucial role in Intraoperative Computed Tomography (iCT), Intraoperative
Magnetic Resonance Imaging (iMRI), and interventional cardiology. Availability
of advanced injector systems for diagnosis and intraoperative imaging has
boosted adoption of these systems. For instance, Medrad Stellant CT injection
system integrated with Certegra Workstation provides high efficiency and
accuracy in CT imaging.
Technological advancements, such as
automated contrast media injectors and double-head injectors, are also among
major factors supporting the growth of the market. Automated contrast media
injectors provide improved patient safety, accuracy, and enhance image quality.
Also, double-head injectors allow a large and rapid initial bolus of contrast,
which is required in several imaging procedures. For instance, in cardiac CT, a
fast injection is required for imaging of both sides of the ventricular septum
to identify septal thickness, shunts, and enlarged ventricles. Delivery of
contrast media is more efficient and controlled with a dual-head injector.
Browse full report by Grand View Research
: http://www.grandviewresearch.com/industry-analysis/contrast-media-injectors
Further Key Findings From the Report Suggest:
·
CT injector systems segment was the largest
revenue-generating segment of the market in 2016 owing to availability of
technologically advanced products and their widespread application for disease
diagnosis and image-guided surgeries
·
The single head injectors segment accounted
for the largest revenue share in 2016 and is expected to maintain its dominance
throughout the study period
·
In the application segment, interventional
cardiology is projected grow at the highest rate during the forecast period
because of rising prevalence of cardiac diseases, such as coronary artery
disease, heart valve disease, and peripheral vascular disease
·
In 2016, hospitals dominated the contrast
media injectors market in terms of revenue because of an increase in the number
of hospital admissions of patients suffering from cancer, neurological
disorders, and cardiovascular diseases
·
The North America contrast media injectors
market held the largest revenue share in 2016 and is projected to maintain its
dominance during the forecast period owing to well-established healthcare
infrastructure
·
Some of the major players are Bayer
HealthCare LLC; Guerbet Group; Bracco Group; Medtron AG; GE Healthcare; Nemoto
Kyorindo Co., Ltd.; Ulrich GmbH & Co. KG; VIVID IMAGING; Sino
Medical-Device Technology Co., Ltd.; and APOLLO RT Co. Ltd.
Browse more reports of this category by Grand View
Research: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global
contrast media injectors market on the basis of product, type, application, end
use, and region:
Product Outlook (Revenue, USD Million; 2014 - 2025)
·
Injector Systems
o CT injector systems
o MRI injector systems
o Cardiovascular/angiography injector systems
·
Consumables
o Tubing
o Syringe
o Others
Type Outlook (Revenue, USD Million; 2014 - 2025)
·
Single Head Injectors
·
Dual-Head Injectors
·
Syringeless Injectors
Application Outlook (Revenue, USD Million; 2014 - 2025)
·
Radiology
·
Interventional Cardiology
·
Interventional Radiology
End-Use Outlook (Revenue, USD Million; 2014 - 2025)
·
Hospitals
·
Diagnostics Centers
·
Ambulatory Surgery Centers
Regional Outlook (Revenue, USD Million; 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
o France
o Italy
o Spain
·
Asia Pacific
o Japan
o China
o India
·
Latin America
o Brazil
o Mexico
·
MEA
o South Africa
o Saudi Arabia
Access press release
by Grand View Research: https://www.grandviewresearch.com/press-release/global-contrast-media-injectors-market
About Grand View
Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information:
http://www.grandviewresearch.com
No comments:
Post a Comment